Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth ...

Since the development of the base and prime editing technique by David Liu at the Broad Institute, their applications in ...

Orionis Biosciences Inc. is sticking with Genentech Inc. in a second deal to discover small-molecule monovalent glue therapies for treating cancer. Privately held Orionis is getting $105 million up ...